Current Neuro-Oncology
Volume
15 Number 12
December 2013
Home > Publications > Current Neuro-Oncology > Volume 15, Year 2013 > Number 12, December
°
Da
Fonseca CO, Teixeira RM, Silva JC, De Saldanha DA Gama Fischer J,
Meirelles OC, Landeiro JA, Quirico-Santos T.
Long-term
outcome in patients with recurrent malignant glioma treated with
Perillyl alcohol inhalation.
Anticancer
Res. 2013 Dec;33(12):5625-31∟.
PMID: 24324108∟.
Retrospective
analysis. ∟
Inoue
A, Harada H, Miura N, Nishikawa M, Fukumoto T, Kohno S, Ohue S,
Tanji N, Ohnishi T.
A
case of neurosurgery for meningioma in a chronic hemodialysis
patient: perioperative management of chronic hemodialysis patients
requiring neurosurgery.
No
Shinkei Geka. 2013 Dec;41(12):1087-92. doi:
10.11477/mf.1436102134🡥.
PMID: 24317885🡥.
Case report; 🡥
Harris
D, Barts A, Connors J, Dahl M, Elliott T, Kong J, Keane T,
Thompson D, Stafford S, Ur E, Sirrs S.
Glucocorticoid-induced
hyperglycemia is prevalent and unpredictable for patients
undergoing cancer therapy: an observational cohort study.
Curr
Oncol. 2013 Dec 1;20(6):e532-8. doi: 10.3747/co.20.1499🡥.
PMID: 24311953🡥.
Observational study. 🡥
Soffietti
R, Trevisan E, Bertero L, Cassoni P, Morra I, Fabrini MG,
Pasqualetti F, Lolli I, Castiglione A, Ciccone G, Rudà R.
Bevacizumab
and fotemustine for recurrent glioblastoma: a phase II study of
AINO (Italian Association of Neuro-Oncology).
J
Neurooncol. 2013 Dec 1. 2014;116(3):533-41. doi:
10.1007/s11060-013-1317-x∟.
PMID: 24293233∟.
Phase 2
trial. ∟
Bandopadhayay
P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S,
Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella
BR, Mitra SS, Cheshier SH, Qi J, Liu KW, Wechsler-Reya R, Weiss
WA, Swartling FJ, Kieran MW, Bradner JE, Beroukhim R, Cho YJ.
BET
Bromodomain Inhibition of MYC-Amplified Medulloblastoma.
Clin
Cancer Res. 2013 Dec 2. 2014;20(4):912-25. doi:
10.1158/1078-0432.CCR-13-2281🡥.
PMID: 24297863🡥.
Laboratory investigation. 🡥
Buglione
M, Pedretti S, Gipponi S, Todeschini A, Pegurri L, Costa L,
Donadoni L, Grisanti S, Fontanella M, Liserre R, Facchetti F,
Padovani A, Magrini SM.
Radiotherapy
in low-grade glioma adult patients: a retrospective survival and
neurocognitive toxicity analysis.
Radiol
Med. 2013 Dec 3. doi:10.1007/s11547-013-0347-y🡥.
PMID: 24297587🡥.
Retrospective analysis. 🡥
Saratsis
AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B,
Hall J, Raabe EH, An P, Weingart M, Rood BR, Magge SN, Macdonald
TJ, Packer RJ, Nazarian J.
Comparative
multidimensional molecular analyses of pediatric diffuse intrinsic
pontine glioma reveals distinct molecular subtypes.
Acta
Neuropathol. 2013 Dec 3. 2014;127(6):881-95. doi:
10.1007/s00401-013-1218-2🡥.
PMID: 24297113🡥.
Laboratory investigation. 🡥
*
Chuang
NA, Yoon JM, Newbury RO, Crawford JR.
Glioblastoma
Multiforme Arising From Dysembryoplastic Neuroepithelial Tumor in
a Child in the Absence of Therapy.
J
Pediatr Hematol Oncol. 2013 Dec 4. 2014;36(8):e536-9. doi:
10.1097/MPH.0000000000000063∟.
PMID: 24309599∟.
Case
report. ∟
Fouse
SD, Nakamura JL, James CD, Chang S, Costello JF.
Response
of primary glioblastoma cells to therapy is patient specific and
independent of cancer stem cell phenotype.
Neuro
Oncol. 2013 Dec 4. 2014;16(3):361-71. doi: 10.1093/neuonc/not223∟.
PMID: 24311636∟.
Laboratory
investigation. ∟
Gill
SK, Wilson M, Davies NP, MacPherson L, English M, Arvanitis TN,
Peet AC.
Diagnosing
relapse in children's brain tumors using metabolite
profiles.
Neuro
Oncol. 2013 Dec 4. 2014;16(1):156-64. doi:
10.1093/neuonc/not143🡥.
PMID: 24305716🡥.
Retrospective analysis. 🡥
Gururangan
S, Fangusaro J, Poussaint TY, McLendon RE, Onar-Thomas A, Wu S,
Packer RJ, Banerjee A, Gilbertson RJ, Fahey F, Vajapeyam S,
Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett
JM, Fouladi M, Kun LE.
Efficacy
of bevacizumab plus irinotecan in children with recurrent
low-grade gliomas--a Pediatric Brain Tumor Consortium study.
Neuro
Oncol. 2013 Dec 4. 2014;16(2):310-7. doi: 10.1093/neuonc/not154🡥.
PMID: 24311632🡥.
Phase 2 trial. 🡥
Hartman
LL, Crawford JR, Makale MT, Milburn M, Joshi S, Salazar AM,
Hasenauer B, Vandenberg SR, Macdonald TJ, Durden DL.
Pediatric
Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed
and Recurrent Brain Tumors.
J
Pediatr Hematol Oncol. 2013 Dec 4. 2014;36(6):451-7. doi:
10.1097/MPH.0000000000000047🡥.
PMID: 24309609🡥.
Phase 2 trial. 🡥
Herrmann
K, Czernin J, Cloughesy T, Lai A, Pomykala KL, Benz MR, Buck AK,
Phelps ME, Chen W.
Comparison
of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for
recurrence detection in glioblastoma patients.
Neuro
Oncol. 2013 Dec 4. 2014;16(4):603-9. doi: 10.1093/neuonc/not166∟.
PMID: 24305722∟
Retrospective
analysis. ∟
Hutterer
M, Nowosielski M, Haybaeck J, Embacher S, Stockhammer F, Gotwald
T, Holzner B, Capper D, Preusser M, Marosi C, Oberndorfer S, Moik
M, Buchroithner J, Seiz M, Tuettenberg J, Herrlinger U, Wick A,
Vajkoczy P, Stockhammer G.
A
single-arm phase II Austrian/German multicenter trial on
continuous daily sunitinib in primary glioblastoma at first
recurrence (SURGE 01-07).
Neuro
Oncol. 2013 Dec 4. 2014;16(1):92-102. doi: 10.1093/neuonc/not161∟.
PMID: 24311637∟.
Ptase 2
trial. ∟
Piscione
PJ, Bouffet E, Mabbott DJ, Shams I, Kulkarni AV.
Physical
functioning in pediatric survivors of childhood posterior fossa
brain tumors.
Neuro
Oncol. 2013 Dec 4. 2014;16(1):147-55. doi:
10.1093/neuonc/not138🡥.
PMID: 24305707🡥.
Retrospective analysis. 🡥
Tran AN,
Lai A, Li S, Pope WB, Teixeira S, Harris RJ, Woodworth DC,
Nghiemphu PL, Cloughesy TF, Ellingson BM.
Increased
sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as
demonstrated by serial quantitative MR volumetry.
Neuro
Oncol. 2013 Dec 4. 2014;16(3):414-20. doi: 10.1093/neuonc/not198∟.
PMID: 24305712∟.
Retrospective
analysis. ∟
Weller
M, Soffietti R, Brada M.
The
legend of cytomegalovirus and glioblastoma lives on.
Neuro
Oncol. 2013 Dec 4. 2014;16(1):166. doi: 10.1093/neuonc/not204∟.
PMID: 24311642∟.
Comment.
∟
Krause
M, Baumann M.
Reduced
acute toxicity for adults with medulloblastoma treated with proton
beam craniospinal irradiation.
Strahlenther
Onkol. 2013 Dec 5. 2014;190(1):111-2. doi:
10.1007/s00066-013-0492-1🡥.
PMID: 24306067🡥.
Retrospective
analysis. 🡥
Pinho
MC, Polaskova P, Kalpathy-Cramer J, Jennings D, Emblem KE, Jain
RK, Rosen BR, Wen PY, Sorensen AG, Batchelor TT, Gerstner ER.
Low
incidence of pseudoprogression by imaging in newly diagnosed
glioblastoma patients treated with cediranib in combination with
chemoradiation.
Oncologist.
2013 Dec 5. 2014;19(1):75-81. doi:
10.1634/theoncologist.2013-0101∟.
PMID: 24309981∟.
Phase
1-2 trial. ∟
Reynés
G, Balañá C, Gallego O, Iglesias L, Pérez P,
García JL.
A
phase I study of irinotecan in combination with metronomic
temozolomide in patients with recurrent glioblastoma.
Anticancer
Drugs. 2013 Dec 5. 2014;25(6):717-22. doi:
10.1097/CAD.0000000000000059∟.
PMID: 24322542∟.
Phase 1
trial. ∟
Della
Puppa A, Gioffrè G, Gardiman MP, Frasson C, Cecchin D,
Scienza R, Persano L.
Intra-operative
5-aminolevulinic acid (ALA)-induced fluorescence of
medulloblastoma: phenotypic variability and CD133(+) expression
according to different fluorescence patterns.
Neurol
Sci. 2013 Dec 7. 2014;35(1):99-102. doi:
10.1007/s10072-013-1597-0🡥.
PMID: 24318560🡥.
Case report. 🡥
Brodin
NP, Munck Af Rosenschöld P, Blomstrand M, Kiil-Berthlesen A,
Hollensen C, Vogelius IR, Lannering B, Bentzen SM, Björk-Eriksson
T.
Hippocampal
sparing radiotherapy for pediatric medulloblastoma: impact of
treatment margins and treatment technique.
Neuro
Oncol. 2013 Dec 9. 2014;16(4):594-602. doi:
10.1093/neuonc/not225🡥.
PMID: 24327585🡥.
Clinical trial. 🡥
Grill
J, Dufour C.
Neuro-oncology:
Stability of medulloblastoma subgroups at tumour recurrence.
Nat
Rev Neurol.
2013 Dec 10. 2014;10(1):5-6. doi: 10.1038/nrneurol.2013.256🡥.
PMID:
24323052🡥.
Comment. 🡥
Refers to:
Ramaswamy
V, et al. Recurrence patterns across medulloblastoma subgroups: an
integrated clinical and molecular analysis.
Lancet
Oncol. 2013 Oct 17. 2013;14(12):1200-7. doi:
10.1016/S1470-2045(13)70449-2🡥.
PMID:
24140199🡥.
Retrospective
analysis.
🡥
Lancet
Oncol. 2014 Mar 31. 2014;15(4):e154. doi:
10.1016/S1470-2045(14)70150-0🡥.
Correction.
🡥
Shen W,
Hu JA, Zheng JS.
Mechanism
of temozolomide-induced antitumour effects on glioma cells.
J
Int Med Res. 2013 Dec 10. 2014;42(1):164-72. doi:
10.1177/0300060513501753∟.
PMID: 24326954∟.
Laboratory
investigation. ∟
Patanè
M, Porrati P, Bottega E, Morosini S, Cantini G, Girgenti V, Rizzo
A, Eoli M, Pollo B, Sciacca FL, Pellegatta S, Finocchiaro G.
Frequency
of NFKBIA deletions is low in glioblastomas and skewed in
glioblastoma neurospheres.
Mol
Cancer. 2013 Dec 11;12:160. doi: 10.1186/1476-4598-12-160∟.
PMID: 24330732∟.
Laboratory investigation. ∟
Greenop
KR, Peters S, Fritschi L, Glass DC, Ashton LJ, Bailey HD, Scott
RJ, Daubenton J, de Klerk NH, Armstrong BK, Milne E.
Exposure
to household painting and floor treatments, and parental
occupational paint exposure and risk of childhood brain tumors:
results from an Australian case-control study.
Cancer
Causes Control. 2013 Dec 12. 2014;25(3):283-91. doi:
10.1007/s10552-013-0330-x🡥.
PMID: 24337771🡥.
Case-control study 🡥
Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse
SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson
SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song
JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM,
Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS,
Chang SM, Taylor BS, Costello JF.
Mutational
analysis reveals the origin and therapy-driven evolution of
recurrent glioma.
Science.
2013 Dec 12. 2014;343(6167):189-193⍈.
doi: 10.1126/science.1239947⍈.
PMID: 24336570⍈.
Laboratory investigation. ⍈
Strother
DR, Lafay-Cousin L, Boyett JM, Burger P, Aronin P, Constine L,
Duffner P, Kocak M, Kun LE, Horowitz ME, Gajjar A.
Benefit
from prolonged dose-intensive chemotherapy for infants with
malignant brain tumors is restricted to patients with ependymoma:
a report of the Pediatric Oncology Group randomized controlled
trial 9233/34.
Neuro
Oncol. 2013 Dec 12. 2014;16(3):457-65. doi:
10.1093/neuonc/not163🡥.
PMID: 24335695🡥.
Randomized. 🡥
Tandon
N, Esquenazi Y.
Resection
strategies in tumoral epilepsy: is a lesionectomy
enough?
Epilepsia.
2013 Dec 12. 2013;54 Suppl 9:72-8. doi: 10.1111/epi.12448🡥.
PMID: 24328877🡥.
Retrospective analysis. 🡥
°
Caignard
A, Faguer R, Mercier P, Menei P, Milea D.
Optic
nerve and visual pathways primary glioblastoma treated with
radiotherapy and temozolomide chemotherapy.
Eur
J Ophthalmol. 2013 Dec 13. 2014;24(4):637-40. doi:
10.5301/ejo.5000416∟.
PMID: 24366773∟.
Case report. ∟
Yamashita
Y, Ito Y, Isomura H, Takemura N, Okamoto A, Motomura K, Tsujiuchi
T, Natsume A, Wakabayashi T, Toyokuni S, Tsurumi T.
Lack
of presence of the human cytomegalovirus in human
glioblastoma.
Mod
Pathol. 2013 Dec 13. 2014;27(7):922-9. doi:
10.1038/modpathol.2013.219∟.
PMID: 24336154∟.
Laboratory
investigation. ∟
Wick W,
Wick A, Platten M.
Challenging
cytomegalovirus data in glioblastoma.
Neuro
Oncol. 2013 Dec 18. 2014;16(1):165. doi: 10.1093/neuonc/not212∟.
PMID: 24353326∟.
Comment.
∟
→Stragliotto
G, et al.
Effects
of valganciclovir as an add-on therapy in patients with
cytomegalovirus-positive glioblastoma: a randomized, double-blind,
hypothesis-generating study.
Int
J Cancer. 2013 Mar 13. 2013;133(5):1204-13. doi:
10.1002/ijc.28111∟.
PMID: 23404447∟.
Phase 1-2 trial. ∟
→Söderberg-Nauclér
C, et al.
Survival in patients with glioblastoma receiving
valganciclovir.
N Engl J Med. 2013 Sep 5;369(10):985-6. doi:
10.1056/NEJMc1302145∟.
PMID: 24004141∟.
Retrospective analysis. ∟
°
Fernandez-Vega
I, Quirk J, Norwood FL, Sibtain NA, Laxton R, Bodi I.
Gliomatosis
cerebri type 1 with extensive involvement of the spinal cord and
BRAF V600E mutation.
Pathol
Oncol Res. 2013 Dec 19. 2014;20(1):215-20. doi:
10.1007/s12253-013-9732-z∟.
PMID: 24353007∟.
Case
report. ∟
Gallego
O, Cuatrecasas M, Benavides M, Segura PP, Berrocal A, Erill N,
Colomer A, Quintana MJ, Balaña C, Gil M, Gallardo A, Murata
P, Barnadas A.
Efficacy
of erlotinib in patients with relapsed gliobastoma multiforme who
expressed EGFRVIII and PTEN determined by immunohistochemistry.
J
Neurooncol. 2013 Dec 19. 2014;116(2):413-9. doi:
10.1007/s11060-013-1316-y∟.
PMID: 24352766∟.
Prospective
study. ∟
J
Neurooncol. 2014 Oct 28. 2014;120(3):667. doi:
10.1007/s11060-014-1643-7∟
Correction.
∟